These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20837868)

  • 1. Dopamine agonist withdrawal syndrome: the apomorphine solution.
    Schlesinger I; Erikh I; Zaaroor M
    Arch Neurol; 2010 Sep; 67(9):1155; author reply 1156. PubMed ID: 20837868
    [No Abstract]   [Full Text] [Related]  

  • 2. [Apomorphine and erectile dysfunction].
    Tan DQ; Yao Y; Zhang J
    Zhonghua Nan Ke Xue; 2007 Sep; 13(9):818-21. PubMed ID: 17929561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DA agonists -- non-ergot derivatives: apomorphine: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S83-9. PubMed ID: 12211146
    [No Abstract]   [Full Text] [Related]  

  • 4. Apomorphine-induced eosinophilic panniculitis and hypereosinophilia in Parkinson disease.
    Pot C; Oppliger R; Castillo V; Coeytaux A; Hauser C; Burkhard PR
    Neurology; 2005 Jan; 64(2):392-3. PubMed ID: 15668455
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of withdrawal syndrome with apomorphine].
    Ziegler B; Schneider E
    Arzneimittelforschung; 1974 Aug; 24(8):1117-9. PubMed ID: 4479363
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of apomorphine in clinical practice.
    MacMahon DG
    Adv Neurol; 1999; 80():529-33. PubMed ID: 10410767
    [No Abstract]   [Full Text] [Related]  

  • 7. A Critical Review of Repurposing Apomorphine for Smoking Cessation.
    Morales-Rosado JA; Cousin MA; Ebbert JO; Klee EW
    Assay Drug Dev Technol; 2015 Dec; 13(10):612-22. PubMed ID: 26690764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of apomorphine in Parkinson's disease.
    Stocchi F
    Neurol Sci; 2008 Dec; 29 Suppl 5():S383-6. PubMed ID: 19381769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Apomorphine treatment of withdrawal symptoms in young opiate addicts].
    Gulmann NC; Kaldan B; Kobbernagal F
    Ugeskr Laeger; 1976 Oct; 138(42):2547-50. PubMed ID: 969008
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of alcohol withdrawal symptoms.
    Mayne DG
    Br J Hosp Med; 1982 Jul; 28(1):102. PubMed ID: 7126967
    [No Abstract]   [Full Text] [Related]  

  • 11. [Apomorphine in opiate withdrawal treatment].
    Hedri A
    Schweiz Rundsch Med Prax; 1972 Apr; 61(15):488-9. PubMed ID: 5022281
    [No Abstract]   [Full Text] [Related]  

  • 12. Apomorphine (TAP holdings). 6a beta-aporphine-10,11-diol hydrochloride hemihydrate, apomorphine hydrochloride, spontane, Uprima.
    Drugs R D; 1999 Dec; 2(6):415-6. PubMed ID: 10763454
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and tolerability of apomorphine SL (Uprima).
    Bukofzer S; Livesey N
    Int J Impot Res; 2001 Aug; 13 Suppl 3():S40-4. PubMed ID: 11477491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dopamine receptor stimulants in the treatment of alcoholism].
    Anokhina IP; Ivanets NN; Reshchikova EV; Nebarakova TP
    Sov Med; 1988; (8):93-5. PubMed ID: 2904705
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypertension and impotence. Which potency drug is the most appropriate here?].
    Köhn FM
    MMW Fortschr Med; 2002 Mar; 144(10):12-3. PubMed ID: 11928255
    [No Abstract]   [Full Text] [Related]  

  • 16. A successful treatment of buprenorphine withdrawal with the dopamine receptor agonist pramipexole.
    Makhinson M; Gomez-Makhinson J
    Am J Addict; 2014; 23(5):475-7. PubMed ID: 24628996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of withdrawal symptoms in "fixers". (Drug abuse of adolescents by intravenous injection)].
    Amitai M; Dickhaut HH; Hasenknopf P
    Nervenarzt; 1972 Mar; 43(3):157-60. PubMed ID: 5023740
    [No Abstract]   [Full Text] [Related]  

  • 18. [Apomorphine].
    Esteban Muñoz J
    Neurologia; 1995 Oct; 10(8):330-7. PubMed ID: 8554783
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of terguride, ropinirole, and acetyl-L-carnitine on methamphetamine withdrawal in the rat.
    Hoefer ME; Voskanian SJ; Koob GF; Pulvirenti L
    Pharmacol Biochem Behav; 2006 Mar; 83(3):403-9. PubMed ID: 16647107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fat necrosis and subcutaneous abscesses due to apomorphine.
    García-Zamora E; Elosua-González M; Floristán-Muruzábal U
    Med Clin (Barc); 2018 Oct; 151(7):294-295. PubMed ID: 29241872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.